22.418 articles found

Therapeutic agents useful for treating pain

GHARAGOZLOO PARVIZ, ISLAM KHONDAKER, KYLE DONALD J, SUN QUN, TAFESSE LAYKEA, WHITEHEAD JOHN WILLIAM FRANK, YANG JI, ZHOU XIAOMING.

· 2003-05-02

Therapy found for Parkinson's disease dyskinesia.

Bradbury J.

Lancet · 2003-05-01

DOI: 10.1016/s0140-6736(03)13388-0PMID: 12767746

Deep brain stimulation for the treatment of Parkinson's disease: the experience of the Neurosurgical Department in Monza.

Landi A, Parolin M, Piolti R, Antonini A, Grimaldi M, Crespi M, Iurlaro S, Aliprandi A, Pezzoli G, Ferrarese C, Gaini SM.

Neurol Sci · 2003-05-01

DOI: 10.1007/s100720300039PMID: 12774214

[Proceedings of the 8th Meeting of Therapeutics and Neurology: Parkinson Disease. 7-8 December 2001, Paris, France].

Check source for author details

Rev Neurol (Paris) · 2003-05-01

PMID: 12773882

[Dopaminergic treatment and parkinsonian syndromes].

Ghawche F, Durif F.

Rev Neurol (Paris) · 2003-05-01

PMID: 12773892

[Treatment of non-dopamine-dependent signs in parkinsonian syndromes: evaluation and results].

Tardieu S, Becker H, Micallef J, Blin O.

Rev Neurol (Paris) · 2003-05-01

PMID: 12773893

Fibrosis associated with dopamine agonist therapy in Parkinson's disease.

Müller T, Fritze J.

Clin Neuropharmacol · 2003-05-01

DOI: 10.1097/00002826-200305000-00001PMID: 12782910

Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoring.

Contin M, Provini F, Martinelli P, Riva R, Albani F, Vetrugno R, Lombardi C, Montagna P, Baruzzi A.

Clin Neuropharmacol · 2003-05-01

DOI: 10.1097/00002826-200305000-00003PMID: 12782912

Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.

Stocchi F, Berardelli A, Vacca L, Barbato L, Monge A, Nordera G, Ruggieri S.

Clin Neuropharmacol · 2003-05-01

DOI: 10.1097/00002826-200305000-00009PMID: 12782918

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets.

Nyholm D, Askmark H, Gomes-Trolin C, Knutson T, Lennernäs H, Nyström C, Aquilonius SM.

Clin Neuropharmacol · 2003-05-01

DOI: 10.1097/00002826-200305000-00010PMID: 12782919

[Comment on revised guidelines in treatment of idiopathic Parkinson syndrome].

Ludin HP.

Praxis (Bern 1994) · 2003-05-01

DOI: 10.1024/0369-8394.92.19.891PMID: 12784496

[Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].

Willeit M, Praschak-Rieder N, Kasper S.

Wien Klin Wochenschr · 2003-05-01

DOI: 10.1007/bf03040333PMID: 12793028